Benchmark Reports

The Ohio Coverdell Stroke Program creates an Annual Benchmark Report for each participating hospital.  This report includes the ten national performance measures for stroke, along with other demographic information and performance indicators.  The report also compares Ohio’s over-all performance on those measures to aggregate national data from more than 3,000 hospitals nationwide reporting data in Get With the Guidelines®-Stroke. 

• View the 2019 report
• View the 2018 report

Defect Free Care

The number of stroke patients who receive defect-free care in Ohio Coverdell hospitals, based on the 10 national performance measures in Get With the Guidelines®-Stroke, increased from 63% of stroke patients receiving defect-free care in 2009 to 80% of stroke patients receiving defect-free care in 2019.  This shows the commitment Coverdell hospitals have made to dramatically improve the quality of care they provide to their stroke patients.

Stroke Performance Measures

The quality of care that stroke patients receive in the hospital can be compared using 10 Stroke Performance Measures developed by The Joint Commission, the American Heart/Stroke Association, and the Centers for Disease Control. Summary graphs of Ohio Coverdell hospitals’ performance (from 2007 through 2017) for each measure are detailed below.

Rapid Treatment of Acute Ischemic Stroke Patients:

This measure describes the percentage of acute ischemic stroke patients who arrived at the hospital within 2 hours from the time stroke symptoms started and who were able to receive t-PA (drugs used to break up or dissolve blood clots) within 3 hours from the time stroke symptoms started. 

Blood Clot Reduction Medication:

This measure describes the percentage of patients with ischemic stroke who received anti-thrombotics (medicine to reduce the formation of blood clots) by the end of their second day in the hospital.

Blood Clot Prevention Treatment Received:

This measure describes the percentage of patients with an ischemic stroke or hemorrhagic stroke who received venous thromboembolism (VTE) prophylaxis (medicine to prevent blood clot formation) by the end of the second day in the hospital. 

Discharged on Blood Clot Reducing Medication:

This measure describes the percentage of patients with an ischemic stroke or a Transient Ischemic Attack (TIA)   who were given a prescription for medicine to prevent blood clots when they were sent home from the hospital.

Atrial Fibrillation Patients Receiving Blood Clot Prevention Medication:

This measure describes the percentage of patients with an ischemic stroke or a Transient Ischemic Attack (TIA) and an irregular heartbeat (atrial fibrillation) who went home from the hospital on medicine to thin their blood and stop blood clots from forming in the heart or lungs. 

Smokers Advised to Quit:

This measure describes the percentage of patients with ischemic or hemorrhagic stroke with a history of smoking cigarettes who were given information about quitting smoking. 

Swallow Screening:

This measure describes the percentage of patients with ischemic or hemorrhagic stroke who were tested for trouble swallowing before being given any food, liquids or medicine by mouth while in the hospital. 

Stroke Education:

This measure describes the percentage of patients with ischemic or hemorrhagic stroke, or their caregivers, who were taught or given printed information while they were in the hospital to help them understand stroke care at home. The education materials should include the following: personal risk factors for stroke, warning signs for stroke, how and when to call 9-1-1, the need to go to the doctor after discharge from the hospital, and how to take medicines at home. 

Rehabilitation Assessment:

This measure describes the percentage of patients with an ischemic or hemorrhagic stroke who were tested to see what type of rehabilitation they needed to help them recover from the effects of their stroke.